TRANQUIL Trademark

Trademark Overview


On Tuesday, April 23, 2024, a trademark application was filed for TRANQUIL with the United States Patent and Trademark Office. The USPTO has given the TRANQUIL trademark a serial number of 98513949. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, May 29, 2024. This trademark is owned by Zoll Respicardia, Inc.. The TRANQUIL trademark is filed in the Medical Instrument Products category with the following description:

Feature of an implantable sleep apnea treatment system, namely an implantable rhythm manager providing variable intensity stimuli
tranquil

General Information


Serial Number98513949
Word MarkTRANQUIL
Filing DateTuesday, April 23, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, May 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesFeature of an implantable sleep apnea treatment system, namely an implantable rhythm manager providing variable intensity stimuli

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, April 23, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameZoll Respicardia, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMinnetonka, MN 55343

Trademark Events


Event DateEvent Description
Tuesday, April 23, 2024NEW APPLICATION ENTERED
Tuesday, April 23, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 20, 2024ASSIGNED TO EXAMINER
Wednesday, May 29, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 29, 2024NON-FINAL ACTION E-MAILED
Wednesday, May 29, 2024NON-FINAL ACTION WRITTEN